Regeneron Pharmaceuticals insider POON CHRISTINE A acquired a total of 180 shares of Common Stock in two separate transactions. On 12/20/2024, 14 shares were granted at $0 per share. Subsequently, on 01/02/2025, an additional 166 shares were acquired, also at no cost.Following these transactions, POON CHRISTINE A's direct ownership increased to 2,352 shares. The acquisitions were reported as grants or awards, indicating they may be part of executive compensation or incentive plans. The transactions are marked as in progress, suggesting potential future related events or filings.

Regeneron Pharmaceuticals insider POON CHRISTINE A acquired a total of 180 shares of Common Stock in two separate transactions. On 12/20/2024, 14 shares were granted at $0 per share. Subsequently, on 01/02/2025, an additional 166 shares were acquired, also at no cost.Following these transactions, POON CHRISTINE A's direct ownership increased to 2,352 shares. The acquisitions were reported as grants or awards, indicating they may be part of executive compensation or incentive plans. The transactions are marked as in progress, suggesting potential future related events or filings.